Company Overview
| Stock Name | 微創醫療科學有限公司 |
|---|---|
| Stock Code | 00853 |
| Company Full Name | 微創醫療科學有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要在中國從事醫療器械之開發、制造及銷售業務。 |
| Listing Date | 2010-09-24 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國上海市張江高科技園區張東路1601號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.microport.com.cn |
| Share Registrar | |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 6.10 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 770,857,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 8.29 |
|---|---|
| First Day Open | HK$ 7.25 |
| First Day Change | 35.90% |
| First Day Volume | 254831000.0 |
| First Day Turnover | 1953430000.0 |
Use of Proceeds
| Use of Proceeds | 1、約50%或714.1百萬港元，用于擴大本集團的產品系列； 2、約25%或357.1百萬港元，用于擴充本集團的生產設施； 3、約20%或285.7百萬港元，用于擴大本集團在中國和世界各地； 4、約5%或71.4百萬港元，用于營運資金及為其他一般企業用途提供資金。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
Credit Suisse (Hong Kong) Limited CE AAO017
Piper Jaffray Asia Limited CE AEG682
Overall Coordinators (1)
Credit Suisse (Hong Kong) Limited CE AAO017
Joint Bookrunners (2)
Credit Suisse (Hong Kong) Limited CE AAO017
PIPER JAFFRAY ASIA SECURITIES LIMITED CE ABO154
Joint Lead Managers (2)
Credit Suisse (Hong Kong) Limited CE AAO017
PIPER JAFFRAY ASIA SECURITIES LIMITED CE ABO154
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Chairman | 常兆華 |
|---|---|
| Company Secretary | 楊兆琳 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | Otsuka Pharmaceutical Co.,Ltd.(20.99%);Maxwell Maxcare Science Foundation Limited(18.00%);Shanghai ZJ Hi-Tech Investment Corporation(12.15%);HHLR Advisors, Ltd.(8.42%);HHLR Fund, L.P.(8.06%) |
|---|
